Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

DeLLphi-301 Investigators, Myung-Ju Ahn, Byoung Chul Cho, Enriqueta Felip, Ippokratis Korantzis, Kadoaki Ohashi, Margarita Majem, Oscar Juan-Vidal, Sabin Handzhiev, Hiroki Izumi, Jong-Seok Lee, Rafal Dziadziuszko, Jürgen Wolf, Fiona Blackhall, Martin Reck, Jean Bustamante Alvarez, Horst-Dieter Hummel, Anne-Marie C Dingemans, Jacob Sands, Hiroaki AkamatsuTaofeek K Owonikoko, Suresh S Ramalingam, Hossein Borghaei, Melissa L Johnson, Shuang Huang, Sujoy Mukherjee, Mukul Minocha, Tony Jiang, Pablo Martinez, Erik S Anderson, Luis Paz-Ares

Research output: Journal article (peer-reviewed) › Journal article

88 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science